Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. (INTS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INTS · as of Jun 9, 2026
Key Statistics
Explore Intensity Therapeutics, Inc. Data
ints stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The INTS analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $125.00, representing +3206.88% upside from the current price of $3.78.
Competitors & Peers
ints competitorsINTS
ANTX
BOLD
IBIO
ITRM
NXTCStock Performance
Full HistoryAbout Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers…
what is intensity therapeutics, inc. · ints stock overview · intensity therapeutics, inc. company profile · who is intensity therapeutics, inc. ceo · ints NASDAQ · intensity therapeutics, inc. headquarters · intensity therapeutics, inc. business segments
About Stock Overview & Key Data
Intensity Therapeutics, Inc. (INTS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 30, 2023. As of the latest trading session, INTS stock price is $3.78, with a market capitalization of $7.1M. The stock has returned -68.76% over the past 12 months and -63.16% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Intensity Therapeutics, Inc. stock is Buy, with an average 12-month price target of $125.00. In fiscal year 2025, Intensity Therapeutics, Inc. reported revenue of — and net income of -$11.6M. For detailed data — including Intensity Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Intensity Therapeutics, Inc. (INTS) stock price is $3.78. The stock is traded on NASDAQ under the ticker symbol INTS. The 52-week range is $3.65 – $43.50.